Glenview Capital Management Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Glenview Capital Management reduced its stake in Monsanto Company by 21.22% during the most recent quarter end. The investment management company now holds a total of 11,091,300 shares of Monsanto Company which is valued at $1,167,359,325 after selling 2,987,128 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Monsanto Company makes up approximately 8.23% of Glenview Capital Management’s portfolio.

Other Hedge Funds, Including , Fred Alger Management Inc added MON to its portfolio by purchasing 331,783 company shares during the most recent quarter which is valued at $34,920,161. Monsanto Company makes up approx 0.17% of Fred Alger Management Inc’s portfolio.Investors Capital Advisory Services reduced its stake in MON by selling 990 shares or 5.5% in the most recent quarter. The Hedge Fund company now holds 17,015 shares of MON which is valued at $1,775,685. Monsanto Company makes up approx 0.34% of Investors Capital Advisory Services’s portfolio.Markston International reduced its stake in MON by selling 60,851 shares or 32.97% in the most recent quarter. The Hedge Fund company now holds 123,700 shares of MON which is valued at $13,204,975. Monsanto Company makes up approx 1.20% of Markston International’s portfolio.Horan Capital Management boosted its stake in MON in the latest quarter, The investment management firm added 22,929 additional shares and now holds a total of 71,137 shares of Monsanto Company which is valued at $7,517,758. Monsanto Company makes up approx 2.00% of Horan Capital Management’s portfolio.

Monsanto Company opened for trading at $106.49 and hit $107.23 on the upside on Thursday, eventually ending the session at $106.91, with a gain of 0.38% or 0.41 points. The heightened volatility saw the trading volume jump to 23,76,404 shares. Company has a market cap of $46,781 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Investors should note that on Aug 12, 2016, Monsanto Company announced a cash dividend of $0.5400. The company’s management has announced Oct 5, 2016 as the ex-dividend date and fixed the record date on Oct 7, 2016. The payable date has been fixed on Oct 28, 2016.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.